search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
96 LONGEVITY CONTROL STRESS (UV-A) 0.001% CSHR EXTRACT + STRESS 1% RESVERATROL + STRESS


Sirtuin 1 ■ Nuclear labelling (DAPI) ■ Figure 5: In situ visualization of sirtuin-1 levels. The white dotted line separates the epidermis and the dermis


When analysed by skin compartment, the extract exhibited 93% efficacy in the stratum corneum, 100% efficacy in the epidermis, and 78% efficacy in the dermis.


LAMP2A levels When compared to the control group, the application of the CSHR extract led to a significant 47% increase in LAMP2A levels (Figure 4). This suggests that the extract stimulates autophagy and enhances the detoxification process, potentially contributing to improved skin longevity.


Sirtuin-1 levels Sirtuin-1 levels (visualized in yellow) were detected in situ using epifluorescence


CONTROL


microscopy (Figure 5). Exposure to UVA stress resulted in a reduction of sirtuin-1 levels. However, both the CSHR extract and resveratrol effectively counteracted this stress-induced decrease in sirtuin-1. Compared to the control, UV-A stress caused


a significant reduction in sirtuin-1 levels. The CSHR extract effectively mitigated this decrease, demonstrating an 83% efficacy and suggesting a longevity-protective effect. The positive control, 1% resveratrol, also protected against the UV-A- induced decline in sirtuin-1 levels, achieving a 68% efficacy.


P16INK4A -positive cells


Compared to the control, the UV stress significantly increased the number of P16INK4A


STRESS (UV-A) -


positive cells. On the contrary, the presence of CSHR extract significantly counteracted (with 89% efficacy) the stress-mediated increase in P16INK4A


properties (Figure 6).


Keratin-14 levels In situ analysis of Keratin-14 levels (depicted in purple) was conducted using epifluorescence microscopy (Figure 7). Exposure to UVA stress resulted in a reduction of Keratin-14 levels. However, the application of the CSHR extract effectively reversed this stress-induced decline in Keratin-14. Compared to the control, UV-A stress led


to a significant reduction in Keratin-14 (K-14) levels. The CSHR extract effectively mitigated


0.001% CSHR EXTRACT + STRESS


-positive cells, suggesting anti-senescent


P16INK4a■ Nuclear labelling (DAPI) ■ Figure 6: In-situ visualization of P16INK4A CONTROL -positive cells. The white dotted line separates the epidermis and the dermis STRESS (UV-A) 0.001% CSHR EXTRACT + STRESS


Keratin 14 ■ Nuclear labelling (DAPI) ■ Figure 7: In situ visualization of K-14 levels. The white dotted line separates the epidermis and the dermis PERSONAL CARE November 2025 www.personalcaremagazine.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107